Pub Date : 1900-01-01DOI: 10.1007/978-3-030-47682-3_6
K. Hess, B. Fellman
{"title":"Examining Performance of Phase I Designs: 3+3 Versus Bayesian Optimal Interval (BOIN)","authors":"K. Hess, B. Fellman","doi":"10.1007/978-3-030-47682-3_6","DOIUrl":"https://doi.org/10.1007/978-3-030-47682-3_6","url":null,"abstract":"","PeriodicalId":144634,"journal":{"name":"Phase I Oncology Drug Development","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115020629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.1007/978-3-030-47682-3_14
F. Janku
{"title":"Incorporating Circulating Biomarkers into Clinical Trials","authors":"F. Janku","doi":"10.1007/978-3-030-47682-3_14","DOIUrl":"https://doi.org/10.1007/978-3-030-47682-3_14","url":null,"abstract":"","PeriodicalId":144634,"journal":{"name":"Phase I Oncology Drug Development","volume":"2065 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127467134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.1007/978-3-030-47682-3_17
V. Sathyanarayanan, S. Iyer
{"title":"The Paradigm of Early Phase Studies in Hematological Malignancies","authors":"V. Sathyanarayanan, S. Iyer","doi":"10.1007/978-3-030-47682-3_17","DOIUrl":"https://doi.org/10.1007/978-3-030-47682-3_17","url":null,"abstract":"","PeriodicalId":144634,"journal":{"name":"Phase I Oncology Drug Development","volume":"106-108 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121193403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.1007/978-3-030-47682-3
T. Yap, J. Rodón, D. Hong
{"title":"Phase I Oncology Drug Development","authors":"T. Yap, J. Rodón, D. Hong","doi":"10.1007/978-3-030-47682-3","DOIUrl":"https://doi.org/10.1007/978-3-030-47682-3","url":null,"abstract":"","PeriodicalId":144634,"journal":{"name":"Phase I Oncology Drug Development","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127770589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}